您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (3): 98-102.doi: 10.6040/j.issn.1671-7554.0.2020.1440

• 临床医学 • 上一篇    下一篇

血浆D-二聚体与109例膀胱癌中发生31例转移的关联性分析

高金梅1,张向莲2,刘铁菊3   

  1. 1.天津医科大学第二医院检验科, 天津 300211;2. 天津医科大学第二医院病理科, 天津 300211;3. 天津医科大学基础医学院病理教研室, 天津 300070
  • 发布日期:2021-04-06
  • 通讯作者: 刘铁菊. E-mail:liutieju@126.com
  • 基金资助:
    国家自然科学基金面上项目(81672870)

Correlation between plasma D-dimer and metastasis in 109 cases of bladder cancer

GAO Jinmei1, ZHANG Xianglian2, LIU Tieju3   

  1. 1. Department of Laboratory, The Second Hospital of Tianjin Medical University, Tianjin 300211, China;
    2. Department of Pathology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China;
    3. Department of Pathology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
  • Published:2021-04-06

摘要: 目的 探讨血浆D-二聚体与膀胱癌发生转移的相关性。 方法 回顾性分析2018年11月至2020年10月于天津医科大学第二医院泌尿外科住院的膀胱癌患者109例。根据影像学检查及术后病理检查结果是否发现淋巴结和/或远处转移,将患者分为转移组(31例)和非转移组(78例)。收集患者同期血液常规检验结果并比较其差异。采用多因素Logistic回归模型分析膀胱癌转移的独立危险因素,绘制受试者工作(ROC)曲线,评价血浆D-二聚体对膀胱癌转移的诊断效能。 结果 转移组D-二聚体中位水平为1.37 mg/L,非转移组为0.53 mg/L。多因素Logistic回归结果显示,膀胱癌患者血浆D-二聚体水平升高可能是肿瘤转移的独立危险因素[OR(95%CI)为9.542(3.521,25.935),P<0.05]。以D-二聚体为变量对膀胱癌转移诊断效能的ROC曲线下面积为0.857(P<0.05),最大约登指数对应的D-二聚体临界值为1.16mg/L。D-二聚体对膀胱癌转移的诊断灵敏度65%、特异度94%、假阴性35%、假阳性6%。 结论 血浆D-二聚体水平升高可能是膀胱癌转移的独立危险因素。

关键词: D-二聚体, 膀胱肿瘤, 转移, 相关性

Abstract: Objective To explore the correlation between plasma D-dimer and metastasis of bladder cancer. Methods The clinical data of 109 patients with bladder cancer admitted to the Urology Department of The Second Hospital of Tianjin Medical University during Nov. 2018 and Oct. 2020 were respectively analyzed. The patients were divided into metastatic group(n=31)and non-metastatic group(n=78 cases)based on the presence of lymph nodes and/or distant metastasis detected by imaging and pathological examinations. Results of routine blood tests were also collected and analyzed. The independent risk factors of metastasis were analyzed with multivariate Logistic regression model. The diagnostic efficacy of plasma D-dimer of metastasis was evaluated with receiver operating characteristic(ROC)curve. Results The median level of D-dimer was 1.37 mg/L in the metastatic group and 0.53 mg/L in the non-metastatic group. Multivariate Logistic regression showed that elevated plasma D-dimer level might be an independent risk factor of metastasis [OR(95%CI): 9.542(3.521, 25.935), P<0.05]. The area under the ROC curve was 0.857(P<0.05), and the cut-off point of plasma D-dimer under the maximum Youden index was 1.16 mg/L. The sensitivity, specificity, false negative value and false positive value of D-dimer of bladder cancer metastasis were 65%, 94%, 35% and 6%, respectively. Conclusion Elevated plasma D-dimer level may be an independent risk factor of metastasis of bladder cancer.

Key words: D-dimer, Bladder cancer, Metastasis, Correlation

中图分类号: 

  • R737.14
[1] 刘杰, 崔伟, 车梓, 等. 经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J]. 山东大学学报(医学版), 2018, 56(7): 81-85. LIU Jie, CUI Wei, CHE Zi, et al. Efficacy of transurethral resection of bladder tumor in the treatment of muscle-invasive bladder cancer [J]. Journal of Shandong University(Health Sciences), 2018, 56(7): 81-85.
[2] Ella G, Christine M, Oliver K, et al. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer [J ]. Thromb Haemost, 2019,(5): 17. doi: 10.1111/jth.14484.
[3] Rubio-Jurado B, Balderas-Pena LM, Garaia-Luna EE. Obesity, Thrombotic risk, and inflammation in cancer [J]. Adv Clin Chem, 2018, 1(85): 71-89.
[4] Mainwaring AM, Wells H, Banks T, et al. Skeletal muscle metastasis to vastus lateralis from a urothelial carcinoma: a case report and review of its diagnosis and management [J]. Case Rep Urol, 2019, 2019:8923780. doi: 10.1155/2019/8923780.
[5] Hiensch R, Belete H, Rashidfarokhi M, et al. Unusual patterns of thoracic metastasis of urinary bladder carcinoma [J]. Clin Imaging Sci, 2017, 5(7): 23. doi: 10.4103/jcis.JCIS_9_17.
[6] Inanc M, Er O, Karaca H, et al. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer [J]. JBUON, 2013,18(2): 391-397.
[7] Dirix L, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer [J]. Br J Cancer, 2002, 86(3): 389-395.
[8] Ya M, Akiyama Y, Okuyama T, et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer[J]. Jap J Clin Oncol, 2001, 31(8): 388-394.
[9] Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival?[J]. Clin Oncol, 2009, 7(27): 4902-4911.
[10] 郑莹莹, 闫卫利. D-二聚体与肿瘤及其血栓形成的研究进展[J]. 医疗装备, 2018, 31(10): 199-200. ZHENG Yingying, YAN Weili. Research progress of D-dimer and tumor and thrombosis [J]. Medical Equipment, 2018, 31(10): 199-200.
[11] Ierodzik M, Karpatkin S. Hypercoagulability preceding cancer. does hypercoagulability awaken dormant tumor cells in the host?[J]. Thromb Haemost, 2005, 5(3): 577-580.
[12] Raphael L, Olivier P. Metastasis: new functional implications of platelets and megakaryocytes [J]. Blood, 2016, 128(1): 24-31.
[13] Schlesinger M. Role of platelets and platelet receptors in cancer metastasis [J]. J Hematol Oncol, 2018,11(1): 125. doi: 10.1186/s13045-018-0669-2.
[14] Schumacher D, Strilic B, Sivaraj KK, et al. Platelet derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor [J]. Cancer Cell, 2013, 24(1): 130-137.
[15] Riedl J, Preusser M, Nazari PMS, et al. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism [J]. Blood, 2017, 129(13): 1831-1839.
[16] Suzuki-Inoue K. Platelets and cancer: pathology and drug targets [J]. Platelets, 2018, 29(8): 771-772.
[17] 解玉卓, 黄伟, 赵涵, 等. 血清CA125、D-二聚体水平与非小细胞肺癌关系研究进展[J].现代肿瘤医学, 2019, 27(7): 1262-1265. XIE Yuzhuo, HUANG Wei, ZHAO Han, et al. Research progression on the relationship between serum CA125 and D-dimer level and non-small cell lung cancer [J]. Journal of Modern Oncology, 2019, 27(7): 1262-1265.
[18] 吴珊, 王冰, 方征, 等. D-二聚体与癌胚抗原和糖链抗原19-9 在胃癌患者肿瘤负荷及疗效评价中的预测价值[J]. 中国临床保健杂志, 2020, 23(2): 220-222. WU Shan, WANG Bing, FANG Zheng, et al. Predictive value of D-dimer, CEA and CA199 in tumor load and therapeutic evaluation of gastric cancer patients [J]. Chinese Journal of Clinical Healthcare, 2020, 23(2): 220-222.
[19] 卜晓敏, 夏亮, 李立文. D-二聚体联合肿瘤标志物在老年肺癌诊断中的价值[J]. 全科医学临床与教育, 2020, 18(5): 397-400. BU Xiaomin, XIA Liang, LI Liwen. Diagnostic value of combined detection of D-dimer and tumor markers in the aged patients with lung cancer [J]. Clinical Education of General Practice, 2020, 18(5): 397-400.
[20] Guo Y, Chen F, Cui W. Usefulness of plasma D-dimer level for monitoring development of distant organ metastasis in colorectal cancer patients after curative resection [J]. Cancer Manag Res, 2018, 10: 4203-4216. doi: 10.2147/CMAR.S177274.
[21] Dai H, Zhou H, Sun Y, et al. Ddimer as a potential clinical marker for predicting metastasis and progression in cancer [J]. Biomed Rep, 2018, 9(5): 453-457.
[22] Takiuchi T, Blake EA, Matsuo K, et al. Aspirin use and endometrial cancer risk and survival [J]. Gynecol Oncol, 2018, 148(1): 222-232.
[23] Adrien Grancher, Pierre Michel, Frédéric Di Fiore, et al. Aspirin and colorectal cancer [J]. Bull Cancer, 2018, 105(2): 171-180.
[1] 古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108.
[2] 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[3] 张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[4] 孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80.
[5] 闫金燕,杨春,李雷,吴福玲,焦永莉,张晓蔚,李晶,张瑞珍,王磊,马香. 山东省儿童百日咳感染与哮喘的相关性[J]. 山东大学学报 (医学版), 2024, 62(7): 33-41.
[6] 宋艳艳,左淑英. 透明细胞肾细胞癌颌下腺转移1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(7): 120-124.
[7] 林雨洋,王蓓,李菲. 大于10 mm甲状腺乳头状癌侧颈区淋巴结转移预测[J]. 山东大学学报 (医学版), 2024, 62(6): 54-64.
[8] 王靖婷,王璟,鲁艺,李静坦,李强,郏雁飞,马晓丽. α5-nAChR与MHC-I在肺腺癌中的表达及相关性[J]. 山东大学学报 (医学版), 2024, 62(5): 72-78.
[9] 刘爱静,李雁儒,高惠茹,段伟丽,李培龙,李娟,杜鲁涛,王传新. 自噬相关蛋白5在结肠癌中的表达及对结肠癌细胞迁移及侵袭能力的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 14-23.
[10] 吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84.
[11] 孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18.
[12] 董雅琪,王新慧,赵颖慧,王传新. 血清外泌体LINC02163作为结直肠癌远处转移标志物的临床价值[J]. 山东大学学报 (医学版), 2023, 61(9): 19-28.
[13] 常晴,刘佳,曲爱林,杨咏梅. 利用数据库信息分析NAMPT与肝癌的病理特征和免疫浸润的关联性[J]. 山东大学学报 (医学版), 2023, 61(4): 26-36.
[14] 郭崇勇,赵朋,刘海盟,王强, 贾宗师,张建. 胸前丘疹为首发表现的胃癌1例[J]. 山东大学学报 (医学版), 2023, 61(4): 119-120.
[15] 邵长秀,贺青卿,庄晓璇,李小磊,周鹏,岳涛,高远,徐婧,李陈钰,郭浩男,庄大勇. 934例甲状腺微小乳头状癌颈淋巴结部位转移及危险因素[J]. 山东大学学报 (医学版), 2023, 61(2): 57-64.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!